🇺🇸 FDA

Company profile · Sponsor

Carisma

Carisma Therapeutics

CARM · NYSE pharma PHILADELPHIA, PA, USA
Pipeline
2
Drugs
0
Patents
2

Quick answer

Carisma (CARM) is a pharma company. headquartered in PHILADELPHIA, PA, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 2 patents to this profile..

Company facts

Ticker CARM
Exchange NYSE
Company type pharma
Headquarters PHILADELPHIA, PA, USA
SEC CIK 0001485003

Pipeline (2)

Search pipeline →

  1. CT-0508

    Carisma

    HER2-positive

    phase 1 mab active

    1 trial

  2. CT-0525

    Carisma

    HER2-positive

    phase 1 small molecule active

    1 trial

Patents (2)

Search patents →

  1. US 11739297

    Method of increasing tumor killing activity of macrophages or monocytes comprising chimeric antigen receptor

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11312939

    Constructs for chimeric antigen receptors

    Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Carisma?

Carisma (CARM) is a pharma company. headquartered in PHILADELPHIA, PA, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 2 patents to this profile..

What pipeline programs does Carisma sponsor?

We track 2 ClinicalTrials.gov-linked programs for Carisma, including CT-0508 and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Carisma company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.